FDA Inspection 1029306 — Aidarex Pharmaceuticals LLC

Aidarex Pharmaceuticals LLC — FEI 3006286571

The FDA completed an inspection of Aidarex Pharmaceuticals LLC on October 20, 2017 in Corona, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 20, 2017
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Corona, CA (United States)

Citations

IDCFRDescription
435721 CFR 211.166(a)Results not used for expiration dates, storage cond.